• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Meetings
    • 2027 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2026 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2026 Proffered Presentations

2026 Proffered Presentations

 

← Back to Previous Page

 

S287: PITUITARY APOPLEXY MANAGED WITHOUT IMMEDIATE SURGERY: A CASE SERIES HIGHLIGHTING CLINICAL AND RADIOGRAPHIC FEATURES ASSOCIATED WITH CONSERVATIVE SUCCESS
Maxwell A Marino, DO, MPH1; Ali O Jamshidi, MD2; 1Riverside University Health System; 2Kaiser Permanente Woodland Hills Medical Center

Introduction: Pituitary apoplexy (PA) often presents with acute headache, cranial neuropathies, and variable visual/endocrine compromise. While urgent decompression remains standard for deteriorating vision or neurological status, a subset can be managed conservatively. We describe demographic, clinical, and imaging features among patients with PA initially treated non-operatively and explore characteristics linked to durable non-surgical outcomes.

Methods: We retrospectively reviewed 16 consecutive patients with imaging and/or clinical diagnoses of PA who were initially managed without surgery at a multi-hospital system (2019–2025). Extracted variables included demographics, presenting symptoms (headache, diplopia/ophthalmoplegia, visual loss), endocrine status, MRI tumor size/extension (suprasellar/chiasmal mass effect; cavernous sinus relationship), immediate management (ICU, steroids, endocrine/ophthalmology evaluation), and longitudinal outcomes (tumor size change, vision, conversion to surgery). Descriptive statistics summarized the cohort.

Results: Median age was 59 years (range 31–79); 60% were male. Headache was common; several had isolated cranial neuropathies (e.g., III or VI), with preserved acuity/fields at presentation. Macroadenomas often showed intrinsic T1 hyperintensity and peripheral enhancement; many lacked frank cavernous sinus invasion. Most patients had either no chiasmal compression or only abutment/mild mass effect at presentation. Initial management emphasized physiologic or stress-dose steroids when indicated, endocrine evaluation, ophthalmologic testing, and short-interval MRI surveillance.

On follow-up, the majority demonstrated radiographic regression or stabilization with symptom improvement (including resolution of cranial neuropathies) and did not require surgery. One patient ultimately underwent delayed endonasal resection due to persistent chiasmal mass effect and symptoms despite observation. Overall conservative success was high, particularly among those without definitive chiasmal compression, with limited or no cavernous sinus invasion, and with isolated cranial nerve palsies rather than global visual loss. Endocrinopathies were common but manageable.

Conclusion: In carefully selected patients with PA—especially those without vision loss from chiasmal compression and with limited parasellar extension—conservative management with intensive endocrine/ophthalmic monitoring and early repeat MRI can be effective. Transient cranial neuropathies frequently improved without surgery. Our series supports an initial non-operative pathway in stable patients, reserving surgery for those with persistent or progressive visual compromise or mass effect.

 

← Back to Previous Page

Copyright © 2026 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved